|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to PRWeb Archives
PRWeb: 10-25-2004
Research and Markets has announced the addition of Fluorescent Proteins: Technologies, Applications, and Opportunities for Drug Discovery to their offering. [PRWEB Oct 25, 2004]
ClinfoSource and the University of Washington have collaborated in offering a ten module online course providing comprehensive coverage of clinical trial conduct for investigative site personnel. This online course qualifies for a maximum of 6.0 category 1 credits toward the AMA Physician's Recognition Award and a maximum of 7.2 contact hours towards Continuing Education for Nurses and Nurse Practitioners. In addition, ClinfoSource offers online training in other modules for GCP training of biopharmaceutical industry professionals and others in allied areas. [PRWEB Oct 24, 2004]
An article by Martha Polovich, MN, RN, AOCNA appears in the September 30, 2004, Online Journal of Issues in Nursing: “Safe Handling of Hazardous Drugs.” Polovich’s article posted to the Online Journal during the same month as an alert from the National Institute for Occupational Safety and Health (NIOSH) on the same subject ("Reducing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings"). Both the article and the NIOSH Alert examine the issue extensively and provide suggested measures for protecting healthcare workers, including use of a closed-system device for safe handling of antineoplastic and other hazardous drugs. In addition to the recent article, Polovich is profiled online at Expert411.com (click the hazardous drugs tab). [PRWEB Oct 23, 2004]
Piribo, the online destination for business intelligence for the biopharma industry, has added a key pharmaceutical intelligence report on the Nitric Oxide market to its collection. [PRWEB Oct 23, 2004]
marcus evans are pleased to announce dates for the annual ManuPharma Europe summit. Following the success of last year’s event, the summit will be held at the Grand Hotel Huis ter Duin in The Netherlands. The event will run from May 16th to 18th 2005 and will bring together senior decision-makers and leading solution provider companies. [PRWEB Oct 23, 2004]
Piribo, the online destination for business intelligence for the biopharma industry, has added another key pharmaceuticals industry reference manual to its collection. [PRWEB Oct 22, 2004]
Research and Markets has announced the addition of Specialty Pharmacies Market Overview to their offering. [PRWEB Oct 22, 2004]
Research and Markets has announced the addition of Antifungals: 2004 and Beyond to their offering. [PRWEB Oct 22, 2004]
Dr. Soltero to address Risk Based Manufacturing as part of a series of educational and training presentations for the International Society for Pharmaceutical Engineering (ISPE) Annual Meeting in October 2004 [PRWEB Oct 22, 2004]
Research and Markets has announced the addition of 'The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being' to their offering. [PRWEB Oct 22, 2004]
MD says, “I lost a parent to Vioxx®.” [PRWEB Oct 21, 2004]
Suggests Topicals instead of Advil® or Ibuprofen. [PRWEB Oct 21, 2004]
A new report indicates that by 2020, half of all American citizens older than 50 will be at risk for fractures from osteoporosis. [PRWEB Oct 21, 2004]
Amadeus International Inc., worldwide leader in developing and marketing flexible compliance process automation software solutions, today announced that they have partnered with US Data Management (USDM), a leading provider of IT and regulatory compliance solutions for the Life Science industry. [PRWEB Oct 21, 2004]
Research and Markets has announced the addition of Early Stage and Discovery Deals: Strategy, Structure and Payment Terms to their offering. [PRWEB Oct 21, 2004]
More than 325 million people worldwide have been helped by the more than 130 biotechnology drugs and vaccines approved by the US FDA. Of the biotech medicines on the market, 70 per cent were approved in the last six years. [PRWEB Oct 21, 2004]
Euroscreen is to help GE Healthcare, a combination of the former Amersham and GE Medical Systems, service researchers in the drug discovery industry through the supply of receptors to GE Healthcare for SPA GPCR assays. [PRWEB Oct 20, 2004]
[PRWEB Oct 20, 2004]
Research and Markets has announced the addition of the revised edition of "Molecular Diagnostics: Transforming Pharmaceuticals, Impacting New Markets" to their offering. [PRWEB Oct 20, 2004]
Piribo, the online destination for business intelligence for the biopharma industry, has added a key disease market report Commercial Insight: HIV - From the Naïve to the Complex to its collection. [PRWEB Oct 20, 2004]
Blacoh Fluid Control was contacted by a major pulp & paper mill in the Northwest who used PCC unloading pumps. [PRWEB Oct 19, 2004]
[PRWEB Oct 19, 2004]
One small start-up company in upstate New York has found a profitable niche in the world of natural health and cosmetic products thanks to the medicinal potential of hot peppers. When SiCap Industries started operations less than a year ago, the company was making a very unique product in the founder's basement. That product known as "Sinus Buster", is the world's first and only hot pepper nasal spray. This all natural nasal spray quickly proved to be a breakthrough in relieving a host of chronic sinus and headache conditions. Thanks to the success of their Sinus Buster nasal spray, SiCap Industries has soared from a literal basement operation into a new 3,500 square foot manufacturing facility. Sinus Buster sales have been so brisk that the company has had no choice but to expand on all levels. SiCap is also set to launch the world's first and only line of hot pepper based health & cosmetic products sometime before Christmas. [PRWEB Oct 18, 2004]
Research and Markets has announced the addition of New Sales Organization Strategy of Pharmaceutical Companies 2004 to their offering. [PRWEB Oct 18, 2004]
An Important Potential Therapy For AIDS Treatment. Euroscreen SA today announced the issuance of a key US patent to ICOS Corporation (“ICOS”) (Nasdaq: ICOS), on protecting antibodies which specifically bind to the CCR5 chemokine receptor. Euroscreen has exclusive worldwide rights to the ICOS CCR5 patent estate, which includes this new patent, under a previous license agreement with ICOS. [PRWEB Oct 17, 2004]
CCR5 Chemokine Receptor is a Crucial Target for a Novel AIDS Therapy. Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key US patent in the area of HIV infection. The patent claims screening methods using the human CCR5 receptor. [PRWEB Oct 17, 2004]
New Formulation Increases Product Efficiency and Improves Product Value for Consumers [PRWEB Oct 16, 2004]
For more than 45 years, Solutions, a family-owned pharmacy in Chattanooga, TN, has been specializing in compounding prescriptions specifically designed by physicians for patients’ needs. [PRWEB Oct 16, 2004]
Men who use Viagra or Cialis for erectile dysfunction (ED) have increases in levels of testosterone, Italian researchers report. [PRWEB Oct 16, 2004]
FDA ordered manufacturers of more than thirty antidepressants to include a black box warning on their labels explaining the drugs increase the risk of suicide in children and adolescents. [PRWEB Oct 15, 2004]
|
|
